NCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids  by Li, Pingping et al.
NCoR Repression of LXRs Restricts
Macrophage Biosynthesis of Insulin-
Sensitizing Omega 3 Fatty Acids
Pingping Li,1,8 Nathanael J. Spann,2,8 Minna U. Kaikkonen,2,5 Min Lu,1 Da Young Oh,1 Jesse N. Fox,2
Gautam Bandyopadhyay,1 Saswata Talukdar,1 Jianfeng Xu,1 William S. Lagakos,1 David Patsouris,1 Aaron Armando,3
Oswald Quehenberger,1,3 Edward A. Dennis,3,4 Steven M. Watkins,6 Johan Auwerx,7 Christopher K. Glass,1,2,*
and Jerrold M. Olefsky1,*
1Department of Medicine
2Department of Cellular and Molecular Medicine
3Department of Chemistry and Biochemistry
4Department of Pharmacology
University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
5A.I. Virtanen Institute, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, P.O. Box 1627, 70211
Kuopio, Finland
6Lipomics Technologies, Inc., West Sacramento, CA 95691, USA
7Laboratory of Integrative and Systems Physiology, Ecole Polytechnique Fe´de´rale de Lausanne, 1015 Lausanne, Switzerland
8These authors contributed equally to this work
*Correspondence: cglass@ucsd.edu (C.K.G.), jolefsky@ucsd.edu (J.M.O.)
http://dx.doi.org/10.1016/j.cell.2013.08.054SUMMARY
Macrophage-mediated inflammation is a major con-
tributor to obesity-associated insulin resistance. The
corepressor NCoR interacts with inflammatory path-
way genes in macrophages, suggesting that its
removal would result in increased activity of inflam-
matory responses. Surprisingly, we find that macro-
phage-specific deletion of NCoR instead results in
an anti-inflammatory phenotype along with robust
systemic insulin sensitization in obese mice. We pre-
sent evidence that derepression of LXRs contributes
to this paradoxical anti-inflammatory phenotype by
causing increased expression of genes that direct
biosynthesis of palmitoleic acid and u3 fatty acids.
Remarkably, the increasedu3 fattyacid levelsprimar-
ily inhibit NF-kB-dependent inflammatory responses
byuncouplingNF-kBbindingandenhancer/promoter
histone acetylation from subsequent steps required
for proinflammatory gene activation. This provides
a mechanism for the in vivo anti-inflammatory
insulin-sensitive phenotype observed in mice with
macrophage-specific deletion of NCoR. Therapeutic
methods to harness this mechanism could lead to a
new approach to insulin-sensitizing therapies.
INTRODUCTION
Insulin resistance is a characteristic pathophysiologic defect in
the great majority of patients with type 2 diabetes mellitus (Haff-
ner and Taegtmeyer, 2003; Olefsky and Glass, 2010; Reaven,200 Cell 155, 200–214, September 26, 2013 ª2013 Elsevier Inc.2005). Obesity is the most common cause of insulin resistance,
and the current obesity epidemic in Westernized countries is
driving the parallel type 2 diabetes epidemic (Shoelson et al.,
2007). Obesity-associated chronic tissue inflammation is a key
mechanism for decreased insulin sensitivity (Olefsky and Glass,
2010), and in obesity, excessive numbers of proinflammatory,
M1-like macrophages accumulate in adipose tissue (Xu et al.,
2003) and liver (Lanthier et al., 2010), where they locally release
a variety of cytokines that act on insulin target cells to impair in-
sulin signaling. Although other immune cell types such as lym-
phocytes, esosinophils, and neutrophils can also contribute to
the tissue inflammatory state in obesity (Kintscher et al., 2008;
Wu et al., 2011; Yang et al., 2010), their function in this context
is largely to regulate macrophage migration and activation.
Inflammatory pathways in macrophages are under stringent
control by a variety of transcription factors and coregulatory mol-
ecules. Among these are NF-kB, AP1, the PPAR family, LXR, and
their associated coactivators and corepressors. As a general
rule, coactivators are recruited to nuclear receptors (NR) by re-
ceptor agonists, whereas corepressors are resident at promoter
regions in the absence of ligands (Glass and Ogawa, 2006). The
major corepressors, nuclear receptor corepressor (NCoR) and
silencing mediator of retinoid and thyroid hormone receptors
(SMRT), are important in the regulation of metabolic processes.
In the basal state, NCoR is resident on a number of inflammatory
pathway genes, keeping them in the repressed state (Medzhitov
and Horng, 2009). Upon signal-dependent inflammatory
pathway activation, NCoR dissociates from the promoter com-
plex, allowing proinflammatory transcription factors, such as
NF-kB and AP1, to induce increased expression of these genes
(Glass and Saijo, 2010; Ogawa et al., 2004).
Although NCoR can be detected on the promoter regions of
genes that are targets of a variety of transcription factors, our
previous studies (Li et al., 2011), as well as those of others (Ya-
mamoto et al., 2011), have shown that deletion of NCoR does
not lead to broad derepression of a large number of transcrip-
tional programs. For example, in adipocytes, the dominant effect
of NCoR knockout (KO) is PPARg derepression (Li et al., 2011),
whereas, in skeletal muscle, PPARd and myocyte enhancer fac-
tor (MEF) activation are the major effects of NCoR gene deletion
(Yamamoto et al., 2011). This leads to the concept that NCoR
has a restricted set of functions within the context of a particular
cell type. Based on these ideas, we used Lys M-Cre-mediated
excision (Clausen et al., 1999) of NCoR to generate macro-
phage/neutrophil NCoR KO mice. Although NCoR can cause
basal repression of inflammatory pathways (Glass and Saijo,
2010), we unexpectedly found that macrophage NCoR KO
mice displayed an anti-inflammatory, insulin-sensitive pheno-
type. Mechanistic studies traced this surprising phenotype to
LXR derepression. Thus, a major effect of NCoR KO in macro-
phages is to derepress LXR, which leads to the induction of
lipogenic pathway genes. This causes increased biosynthesis
of palmitoleic acid (POA) andu3 fatty acids withinmacrophages,
which exert robust local anti-inflammatory effects and are asso-
ciated with the in vivo insulin sensitive phenotype.
RESULTS
Creation of Macrophage/Neutrophil-Specific NCoR
Knockout Mice
Mice carrying ‘‘floxed’’ NCoR alleles, with LoxP sites flanking
exon 11 of the NCoR gene, were crossbred with mice transgenic
for Lys M-driven Cre expression. Both of these mouse lines have
been extensively bred (>10 generations) to the C57B/6J back-
ground. Because Lys M is highly expressed in macrophage/
neutrophil lineages, the resulting NCoRF/F,Lys M-Cre mice
exhibit NCoR deletion in these cell types. Consistent with our
previous studies (Hevener et al., 2007), this system is highly
efficient for generation of tissue-specific NCoR KO mice and
resulted in 80%–90% deletion of NCoR frommacrophages (Fig-
ures 1A and 1B). For convenience, these animals are hereafter
referred to as MNKO mice.
Metabolic Studies in Wild-Type and MNKO Mice
MNKO mice exhibited normal fertility, and their offspring fol-
lowed the predicted Mendelian pattern with no developmental
abnormalities noted. On normal chow diet, wild-type (WT) and
MNKO mice reached the same body weight, whereas the
MNKO group was modestly more insulin sensitive during insulin
tolerance test (ITT) testing (data not shown). When placed on
60% high-fat diet (HFD) for 12 weeks, WT and MNKO mice ex-
hibited similar increases in body weight (Figure 1C) and fat
mass (Figure 1D). Given the known function of NCoR to repress
basal expression of macrophage inflammatory pathway genes,
we predicted increased inflammation and insulin resistance in
the HFD MNKO mice. Surprisingly, insulin and free fatty acid
(FFA) levels were significantly lower in HFD KO mice compared
to WT littermates (Figures 1E and 1F), indicating an improved
overall metabolic phenotype. This phenotype was more robust
following oral glucose administration, which revealed enhanced
glucose tolerance (Figure 1G) in MNKO animals. Together, withthe reduced basal insulin levels, these results indicate that dele-
tion of NCoR frommacrophages confers a systemic insulin-sen-
sitive phenotype.
To quantitate this effect and to identify tissue-specific re-
sponses, we performed hyperinsulinemic-euglycemic clamp
studies (Li et al., 2011), which quantitatively assess insulin action
in target tissues in vivo. The HFD MNKO mice were markedly
more insulin sensitive compared to HFDWTmice. This wasman-
ifested by an increased overall glucose infusion rate (GIR) (Fig-
ure 1H) and glucose disposal rate (GDR) (Figure 1I). In addition,
HFDMNKOmice exhibited enhanced insulin-stimulated glucose
disposal rate (IS-GDR, a measure of skeletal muscle insulin
sensitivity) (Figure 1J) and an increased ability of insulin to sup-
press hepatic glucose production (HGP, Figure 1K) and circu-
lating FFA levels (Figure 1L). Thus, the MNKO mice displayed
greater in vivo insulin sensitivity in all three major insulin target
tissues, muscle, liver, and fat. Interestingly, treatment of HFD
WT mice with rosiglitazone (3 weeks) led to the expected in-
crease in systemic insulin sensitivity; however, the untreated
MNKO mice were already insulin sensitive, and rosiglitazone
treatment had little, if any, additive beneficial effect (Figures
1H–1L).
Inflammatory Signaling and Macrophage Function
Given the unexpected insulin-sensitive phenotype in the MNKO
mice, we characterized inflammatory pathway signaling in WT
and NCoR-depleted macrophages. We measured messenger
RNA (mRNA) expression levels of a variety of inflammatory genes
in the basal state and after TLR4 (KLA), TLR3 (Poly(I:C)), and
TLR2 (Pam3CSK4) stimulation in thioglycollate-elicited intraper-
itoneal macrophages (i.p. Macs) obtained from WT and MNKO
mice (Figure 2). Consistent with the in vivo results for glucose
homeostasis and insulin sensitivity, basal gene expression was
decreased in the MNKO macrophages (Figure 2A), and, more
importantly, NCoR deletion led to broadly impaired inflammatory
responses to TLR4, TLR2, and TLR3 agonists (Figures 2B–2D).
Complementing the results in macrophages from MNKO mice,
RNAi-mediated depletion of NCoR in WT macrophages results
in the same attenuation of inflammatory gene responses (Fig-
ure 2E). Interestingly, a subset of genes characteristic of alterna-
tively activated, M2-like, macrophages exhibited increased
expression in NCoR KO cells in the basal state and after IL-4
stimulation (Figures 2F and 2G).
In light of the reduced inflammatory state in the MNKO mice,
we went on to measure systemic aspects of HFD-mediated
inflammation (Figure 3). As can be seen in Figures 3A–3D, circu-
lating levels of multiple cytokines, typically released by macro-
phages, were lower in the MNKO mice compared to WT, which
is fully consistent with the gene expression data in Figure 2. In
addition, the circulating TNFa levels were lower in MNKO mice
as compared to WT mice following lipopolysaccharide (LPS)
administration in vivo (Figure S1A available online). Immunohis-
tochemical analyses of adipose tissue sections were conducted
by staining of adipose tissue sections for the macrophage
marker F4/80 (Figure 3E), which revealed that adipose tissue
from MNKO mice contained fewer macrophages compared to
WT mice. We extended this finding by performing fluores-
cence-activated cell sorting (FACS) studies of adipose tissueCell 155, 200–214, September 26, 2013 ª2013 Elsevier Inc. 201
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Figure 1. Improved Glucose Metabolism
and Insulin Sensitivity of MNKO Mice
(A) Shown (top to bottom) are WT, floxed, and
deleted NCoR gene loci.
(B) Relative messenger RNA levels of NCoR in
macrophages. Values are fold induction of gene
expression normalized to the housekeeping gene
36B4 and expressed as mean ± SEM.
(C) Body weight of WT and KO mice on 60% HFD.
(D) Epi-WAT mass.
(E) Fasting blood insulin levels.
(F) Fasting FFA levels.
(G) Glucose tolerance tests.
(H) GIR during hyperinsulinemic euglycemic
clamp.
(I) GDR.
(J) IS-GDR.
(K) Percent suppression of HGP by insulin (HGP
suppression).
(L) Percent suppression of free FA levels (FFA
suppression).
Values are expressed as mean ± SEM. *p < 0.05,
**p < 0.01 for KO versusWT, or for comparisons as
indicated.stromal vascular cells (SVCs) (Figure 3F), which demonstrated
reduced macrophage content, as well as decreased CD11c+
proinflammatory macrophages in the MNKO mice.
Macrophages and adipocytes are the cellular sources of che-
mokines in adipose tissue of obese mice, and the decreased
expression of MCP-1 and keratinocyte-derived chemokine
(KC) (Figure 3A) is one mechanism for decreased adipose tissue
macrophage (ATM) accumulation. However, we considered
whether the intrinsic chemotactic properties of NCoR-depleted
macrophages were impaired. To this end, we conducted
in vitro chemotaxis experiments. We found that the ability of202 Cell 155, 200–214, September 26, 2013 ª2013 Elsevier Inc.NCoR KO i.p. Macs to migrate toward
adipocyte-conditioned medium (CM)
was substantially impaired compared to
WT cells (Figure 3G), providing an addi-
tional mechanism for reduced ATMs and
decreased inflammatory status in the
MNKO mice.
Consistent with the reduced intrinsic in-
flammatory state of NCoR-depleted
macrophages and the decreased ATM
accumulation in HFD MNKO mice, we
also found decreased epididymal white
adipose tissue (eWAT) expression of a
number of proinflammatory genes typi-
cally associated with the inflammatory/in-
sulin-resistant state (Figure 3H). A similar
decrease in inflammatory gene expres-
sion was observed in perirenal, subcu-
taneous, and brown adipose tissue
(BAT) fromHFDMNKOmice (Figure S1B).
Interestingly, although the overall degree
of inflammation and ATM accumulation
was less in subcutaneous WAT and BATrelative to eWAT and perirenal fat, the decreased inflammation
in the MNKO fat depots was still evident. Similar to adipose tis-
sue, hepatic inflammation also occurs in obesity with increased
numbers of recruited hepatic macrophages (RHMs), which are
distinct from Kupffer cells, and increased inflammatory gene
expression. As seen in Figure S1C, macrophage markers (F4/
80 and CD11c) and inflammatory gene expression are reduced
in liver tissue from HFD MNKO mice compared to WT controls.
The mechanism of inflammation-induced insulin resistance
largely involves local release of inflammatory mediators, which
exert paracrine effects to directly diminish insulin signaling in
insulin target cells (Jager et al., 2007; Rotter et al., 2003). To
assess this mechanism in MNKO and WT mice, CM was har-
vested from basal and LPS-treated WT and MNKO macro-
phages. L6 myocytes were then treated with CM, followed by
measurements of insulin-stimulatedglucose transport (Figure 3I).
After treatment with basal CM, myocyte glucose transport was
substantially higher with MNKOCM administration. LPS stimula-
tion leads to a marked increase in cytokine release by macro-
phages, and consequently, CM harvested from the LPS-treated
WT cells robustly decreased the ability of insulin to stimulate
transport in myocytes (Figure 3I). In contrast, CM from LPS-
treated MNKO cells was without effect to inhibit insulin action.
These findings indicate that CM fromWTmacrophages contains
factors (most likely cytokines), which attenuate insulin signaling,
and that this is more pronounced after LPS stimulation. CM from
theMNKO cells contains less insulin-resistance-promoting cyto-
kines, which is consistent with the results in Figures 1, 2, 3, and
S1. It is also possible that CM from MNKO cells contains factors
that potentiate insulin-stimulated glucose transport.
Genome-wide Consequences of NCoR Deletion on
Inflammatory Response Genes
The unexpected insulin-sensitive phenotype of MNKO mice and
the hyporesponsiveness of the corresponding macrophages to
Toll-like receptor (TLR) agonists prompted us to evaluate
the consequences of NCoR deletion in macrophages on a
genome-wide scale. We next used global run-on sequencing
(GRO-seq) analysis to quantify nascent RNAs that are actively
being transcribed in macrophages fromWT andMNKOmice un-
der basal conditions or upon activation with the TLR4 agonist
KLA. GRO-seq thereby provides a more direct measure of tran-
scription rates than total mRNA levels. Using this approach, we
identified 3,397 expressed transcripts with RefSeq annotations
that were >1.5-fold increased in MNKO versus WT macro-
phages under basal conditions, exemplified by Mmp12 (Fig-
ure 4A). Conversely, 1,746 expressed transcripts were reduced
>1.5-fold in MNKO compared to WT macrophages. Unexpect-
edly, the overall pattern of differential gene regulation under
basal conditions is consistent with roles of NCoR in both positive
and negative regulation of innate immune functions. In partic-
ular, downregulated genes were significantly enriched for
functional annotations linked to immune response, defense
response, and inflammatory response (Figure 4B). Furthermore,
a number of the RefSeq transcripts induced more than 2-fold in
WT macrophages following 1 hr of KLA treatment exhibited
<50% of maximal activation in MNKO macrophages, as exem-
plified by Nos2 and Cxcl10 (Figures 4C and 4D). Indeed, a direct
comparison of the KLA-stimulated induction of these induced
genes in WT macrophages showed that 26% of these genes
achieved levels of induction in MNKO macrophages that were
66% or less than in WT macrophages (indicated by red data
points in Figure 4E and by box plot in Figure S2). We define
this subset of KLA-induced genes as hypo-responsive, and
collectively, they specify a genome-wide signature of the hypo-
responsive MNKO phenotype. Visualization of GRO-seq tag
density for the hyporesponsive set of genes indicated no
changes in levels of transcripts from paused Pol II at the
transcriptional start site but indicated uniform reduction in tagdensities throughout the gene bodies under KLA-stimulated
conditions (Figure 4F).
To investigate consequences of NCoR deletion on deposition
of a histone acetylation mark associated with transcriptional
activation (Hargreaves et al., 2009), we performed ChIP-seq
analysis of histone H4 lysine 5 acetylation (H4K5ac) and of
NCoR in WT and MNKO macrophages. As expected, H4K5ac
was increased in the vicinity of NCoR binding sites in MNKO
macrophages (Figure 4G), which is consistent with a role of
NCoR in recruiting histone deacetylase 3 (HDAC3) to these loca-
tions (Figure S2B). Evaluation of H4K5ac at specific loci illus-
trated the expected increase at genes exhibiting upregulation
in MNKO cells, exemplified by the Mmp12 locus (Figure 4A).
However, H4K5ac was also increased at genes exhibiting hypo-
responsiveness to KLA stimulation, exemplified by the Nos2 and
Cxcl10 genes (Figures 4C and 4D). As shown in Figure 4H, this
pattern was observed for the entire set of hyporesponsive genes
in MNKO cells. ChIP analysis confirmed that, in MNKO macro-
phages, HDAC3 binding is significantly reduced at NCoR sites
on inflammatory loci demonstrating both hyperacetylation and
TLR4 hyporesponsiveness, as exemplified by Nos2, IL-1b, and
Cxcl10 (Figure S2C).
NCoR Deficiency Induces an LXR Program Leading to
Altered Fatty Acid Metabolism
Based on these results, we evaluated genes that were de-
repressed in MNKO macrophages for functions that might
negatively regulate the TLR4 signaling pathway. Interestingly,
derepressed genes were significantly enriched for functional
annotations linked to fatty acid metabolism, including the terms
linoleic acidmetabolism, biosynthesis of unsaturated fatty acids,
and a linoleic acid metabolism (Figure 4B). Further, several of
the derepressed genes encode enzymes involved in the syn-
thesis of monounsaturated (MUFA) and polyunsaturated fatty
acids (PUFA) that have been documented to have anti-inflamma-
tory and/or insulin-sensitizing effects (Oh et al., 2010; Spann
et al., 2012). These included Elovl5, Fads1, and Fads2, involved
in the elongation and desaturation of long-chain fatty acids to
generate anti-inflammatory PUFAs, and Scd1/Scd2, which cata-
lyze the synthesis of 16:1 POA, suggested to be an insulin-sensi-
tizing adipokine (Cao et al., 2008). Quantitative PCR assays
confirmed significant upregulation of Fads2, Elovl5, and Scd2
(Figure 5A).
Prior ChIP-seq studies of the LXRb cistrome in macrophages
indicate that several of these genes are direct targets of liver X
receptors (LXRs) (Heinz et al., 2010). Studies in LXR-deficient
mice demonstrated that, in the unliganded state, LXRs mediate
active repression at select LXR target genes dependent on inter-
action with NCoR (Wagner et al., 2003). Consistent with these
prior findings, a significant fraction of known LXR target genes
is derepressed in MNKO cells, including Abca1 and Fasn (Fig-
ure 5A), suggesting that upregulation of LXR target genes
involved in fatty acid metabolism in MNKO macrophages could
be a consequence of locus-specific derepression of LXR. In
agreement with this possibility, overlap of ChIP-seq data re-
vealed a high degree of colocalization of NCoR with LXRb bind-
ing sites in the macrophage (Figure 5B). Given that motif analysis
verifies that these sites as likely bona fide LXR binding sitesCell 155, 200–214, September 26, 2013 ª2013 Elsevier Inc. 203
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Figure 2. Reduced Inflammation in i.p. Macrophages of MNKO Mice
(A) Relative mRNA levels of inflammatory cytokines in i.p. macrophages without treatment.
(B) Relative mRNA levels of inflammatory cytokines in i.p. macrophages with TLR4 agonist treatment.
(C and D) (C) Relative mRNA levels of inflammatory cytokines in i.p. macrophages after TLR2 agonist treatment or (D) TLR3 agonist treatment.
(legend continued on next page)
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Figure 3. Hypoinflammatory Phenotype of MNKO Mice
(A–D) Inflammatory cytokine expression in serum, including IL-6 (A), KC (B), MIP-1a (C), and MCP-1 (D).
(E) F4/80 staining in Epi-WAT of WT and MNKO mice.
(F) FACS analysis of macrophages and CD11c-positive macrophage content in Epi-WAT.
(G) Chemotaxis assay on the i.p. macrophages from WT and MNKO mice.
(H) Proinflammatory cytokine expression in Epi-WAT from WT and MNKO.
(I) Effect of conditioned medium from i.p. macrophages treated with LPS on glucose uptake in L6 cells.
Values are expressed as mean ± SEM. *p < 0.05, **p < 0.01. See also Figure S1.(Figure 5C), and that NCoR tag densities demonstrating most
significant enrichment precisely centered on LXRb peaks (Fig-
ure 5D), it is likely that loss of NCoR would have a significant(E) Relative mRNA levels of NCoR and indicated inflammatory cytokines in c
treatment.
(F and G) (F) Relative mRNA levels of M2-like cytokines in i.p. macrophages with
Values are relative to GAPDH and are expressed as mean ± SEM. *p < 0.05, **prole at many of these loci containing LXR-NCoR complexes nor-
mally poised for active repression under basal conditions.
Consistent with this, direct measure of LXR complex activity byontrol (siCTL) versus siNCoR-treated i.p. macrophages after TLR4 agonist
out IL-4 treatment or (G) with IL-4 treatment.
< 0.01 for KO versus WT, or siCTL versus si NCoR in 2E.
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Figure 4. Genome-wide Impact of NCoR Deletion
(A) UCSC genome browser image illustrating normalized tag counts for H4K5Ac ChIP-seq, GRO-seq, and NCoR ChIP-seq (Barish et al., 2012) in WT and MNKO
macrophages at the Mmp12 locus.
(B) Functional KEGG annotations associated with genes demonstrating increased or reduced expression in MNKO macrophages by more than 1.5-fold.
(C and D) UCSC genome browser images corresponding to (A) for the Nos2 and Cxcl10 genomic loci.
(E) Scatter plot of fold change of genes induced >2-fold by 1 hr KLA treatment inWTmacrophages versus fold change of the same genes inMNKOmacrophages.
Fold activation is plotted as normalized GRO-seq tag counts for genes comparing log2 values of KLA versus vehicle treated. MNKO hyporesponsive genes are
highlighted in red. The Pearson’s correlation coefficient is reported in the figure (p < 0.0001).
(F) Normalized distribution of GRO-seq tag counts in the vicinity of the transcriptional start sites of TLR4-responsive genes exhibiting compromised activation in
MNKO macrophages.
(G) Normalized distribution of H4K5Ac ChIP-seq tag counts in the vicinity of NCoR binding sites under basal conditions.
(legend continued on next page)
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Figure 5. Impact of NCoR KOon LXR Target
Gene Expression in Macrophages
(A) qPCR analysis of the indicated LXR target
genes in WT and MNKO macrophages.
(B) Venn diagram of overlap between LXRb and
NCoR peaks in macrophages.
(C) Sequence motifs associated with LXRb and
NCoR cobound sites.
(D) Distribution of NCoR ChIP-seq tag density in
the vicinity of LXRb binding sites.
(E) LXR-dependent Abca1-luciferase reporter as-
says in WT and MNKO macrophages.
(F) Distribution of H4K5ac ChIP-seq tag density in
the vicinity of LXRb binding sites.
(G) UCSC genome browser image illustrating
normalized tag counts for H4K5Ac ChIP-seq,
GRO-seq, LXRb ChIP-seq, and NCoR ChIP-seq
(Barish et al., 2012) at the Scd2 locus.
Values are expressed as mean ± SEM. *p < 0.05
and **p < 0.01 for KO versus WT.use of luciferase reporter constructs revealed that MNKO mac-
rophages demonstrated significantly higher LXR reporter activity
from a construct driven by LXR-binding sites from the Abca1 lo-
cus (Figure 5E). Further, LXR binding sites were associated with
increased H4K5ac in MNKO macrophages (Figure 5F) and
increased expression of nearby genes, exemplified byScd2 (Fig-
ure 5G, track 2). Accordingly, the Scd2 locus enhancer region
occupied by LXR and NCoR (Figure 5G, tracks 3 and 4) indicates(H) Normalized distribution of H4K5Ac ChIP-seq tag counts in the vicinity of transcriptional start sites (TSS
H4K5Ac tag counts are presented as averages at indicated positions of KLA-activated genes demonstrating h
MNKO hyporesponsive loci are chosen according to those genes demonstrating 1.5-fold decrease in KLA r
comparison of normalized GRO-seq tag counts of MNKO versus WT macrophages.
See also Figure S2.
Cell 155, 200–214, Sea marked increase in H4K5ac (Figure 5G,
upper track). Collectively, these data indi-
cate that one significant consequence of
NCoR deletion in the macrophage is
derepression of LXR target genes,
including those that control fatty acid
metabolism.
These findings suggested that NCoR
KO macrophages might exhibit re-
programming of fatty acid metabolism,
generating lipid productswith anti-inflam-
matory effects. To assess this, we per-
formed a lipidomic analysis on WT and
NCoR KO i.p. Macs (Figure 6A). 18:3n3 li-
nolenic acid (ALA) is a precursor for the
biosynthetic pathway, containing the
gene products of Fads1, Fads2, and
Elovl5, whose enzymatic activities enable
production of the long chain u3 FAs
20:5n3(EPA) and 22:6n3(DHA). Impor-
tantly, ALA concentrations are markedly
decreased in the NCoR KO macro-
phages, whereas levels of EPA and DHAwere 4- to 6-fold increased (Figure 6A). The potent anti-inflam-
matory effects of u3 FAs are well known (Mori and Beilin,
2004; Oh et al., 2010), providing a potential mechanistic explana-
tion for the decreased overall inflammatory tone of the MNKO
mice. Furthermore, Cao et al. (2008) identified palmitoleic acid
(16:1n7, POA) as a ‘‘lipokine’’ that can exert insulin-like actions.
In addition, recent studies have demonstrated that POA exhibits
potent anti-inflammatory activity in macrophages (Spann et al.,) under basal conditions. For Figures 4G and 4H,
yporesponsiveness in MNKOmacrophages. TLR4
esponse of MNKO relative to WT, as measured by
ptember 26, 2013 ª2013 Elsevier Inc. 207
*WT KO
0.0
0.1
0.2
0.3
0.4
*
ALA
pm
o
l /
 
m
ill
io
n
 
c
e
lls
WT KO
0
1
2
3
4
5
**
EPA
pm
o
l /
 
m
ill
io
n
 c
e
lls
WT KO
0
10
20
30
40
50
**
DHA
pm
o
l /
 
m
ill
io
n
 
c
e
lls
0
20
40
60
80
100
120
140
160
500
750
1000
1250
1500 WT KO
*
**
*
P
am
it
o
le
a
te
pm
o
l /
 
m
ill
io
n
 
c
e
lls
0
20
40
60
80
100
120
140
2000
4000
6000
8000 WT KO
**
**
*
pm
o
l /
 
m
ill
io
n
 c
e
lls
0.0
5.0
10.0
15.0
300
500
700
900 WT KO
*
**
*
pm
o
l /
 
m
ill
io
n
 c
e
lls
EPA
DHA
Pamitoleate
A
C
B
D
Total 
Phospholipid
TriacylglycerolDiacylglycerolCholesterol Ester
DiacylglycerolCholesterol Ester
DiacylglycerolCholesterol Ester
F
G
WT KO
0
2
4
5
6
7
Pamitoleate
pm
o
l /
 
m
ill
io
n
 
c
e
lls
1
3
H
E
0
Tnfα Ifnγ
0
Il6
0
0
1
2
3
Cxcl10
R
e
la
tiv
e
 
m
R
N
A
 le
v
e
l
0
0.2
0.8
1.0
1.2
1.4
Il-1β
0
0.20
0.25
0.30
0.35
0.6
0.4
WT
NCoR KO
WT
NCoR KO
0.05
0.10
0.15
Nos2
WT
NCoR KO
R
e
la
tiv
e
 m
R
N
A
 
le
v
e
l
0.5
2.5
2.0
1.5
1.0
WT
NCoR KO
0.0020
0.0025
0.0030
0.0035
0.0005
0.0010
0.0015
WT
NCoR KO
0.20
0.25
0.30
0.35
0.05
0.10
0.15
WT
NCoR KO
Total 
Phospholipid
Triacylglycerol
Total 
Phospholipid
Triacylglycerol
KLA _ + +
EPA _ _ +
KLA _ + +
EPA _ _ +
KLA _ + +
EPA _ _ +
KLA _ + +
EPA _ _ +
KLA _ + +
EPA _ _ +
KLA _ + +
EPA _ _ +
notx
KLA
*
****
**
†
†
†
0
Cxcl10
0
Nos2
siCtrl +
siElovl5 _
_
+
KO
+
_
_
+
WT
siCtrl +
siElovl5 _
_
+
KO
+
_
_
+
WT
10
20
30
5
15
25
0.3
0.7
0.6
0.5
0.4
0.2
0.1
0
Cxcl10
0
Nos2
siCtrl +
siFads2 _
_
+
KO
+
_
_
+
WT
siCtrl +
siFads2 _
_
+
KO
+
_
_
+
WT
10
20
25
5
15
0.3
0.7
0.6
0.5
0.4
0.2
0.1
0
Cxcl10
0
Nos2
siCtrl +
siScd2 _
_
+
KO
+
_
_
+
WT
siCtrl +
siScd2 _
_
+
KO
+
_
_
+
WT
10
20
30
5
15
25
0.6
1.4
1.2
1.0
0.8
0.4
0.2
notx
KLA
notx
KLA
notx
KLA
notx
KLA
notx
KLA
**
**
**
**
*
*
R
el
a
tiv
e
 
m
R
N
A
 
le
v
e
l
R
e
la
tiv
e
 
m
R
N
A
 
le
v
e
l
R
el
a
tiv
e
 
m
R
N
A
 
le
v
e
l
(legend on next page)
208 Cell 155, 200–214, September 26, 2013 ª2013 Elsevier Inc.
2012). In line with increased expression of Scd1 and Scd2, the
levels of POAwere also 2- to 3-fold increased in theMNKOmac-
rophages (Figure 6A). We also measured EPA, DHA, and POA
concentrations within each of the major lipid classes, finding in-
creases in the cholesterol ester and triacylglycerol fractions, but
not in total phospholipids (Figures 6B–6D).
No appreciable differences in circulating EPA, DHA, or POA
levels were observed in MNKO mice compared to WT mice
(data not shown), suggesting that the biological consequences
of increased production of these lipid species would most likely
result from autocrine or paracrine mechanisms. To investigate
this possibility, we first evaluated the impact of EPA on TLR
responses in macrophages derived from WT and MNKO ani-
mals. As expected, EPA treatment strongly suppressed the
KLA response of Cxcl10, Nos2, Il1b, Tnf, and Ifng in WT macro-
phages (Figure 6E). In MNKO macrophages, responses of
Cxcl10, Nos2, Il1b, Tnf, and Ifng to TLR4 ligation were reduced,
as previously noted. With the exception of IL6, the inhibitory
effects of EPA were much less robust in MNKO versus WT mac-
rophages, which is consistent with increased endogenous levels
of u3 FAs in the MNKO macrophages.
To further investigate roles of endogenous POA and u3 FAs in
determining the MNKO phenotype, we used an RNAi approach
to knock down Fads2, Elovl5, and Scd2 in both WT and MNKO
macrophages. Knockdown of these enzymes responsible for
the production of POA and u3 FAs (Figure S3) led to increased
KLA-stimulated inflammatory gene expression of MNKO hypo-
responsive genes, exemplified by Cxcl10 and Nos2 (Figures
6F–6H). The knockdowns demonstrated direct target specificity,
as known LXR target genes such as Abca1 and Abcg1 were not
reduced by the siRNAs, relative to the specific target genes
Fads2, Elovl5, and Scd2 (Figures S3A–S3C). Further, the
siRNA-mediated derepression of TLR target genes was mainly
selective for the hyporesponsive genes in the MNKO cells.
Thus,many of the KLA-stimulated genes, either hyperresponsive
or unaffected by loss of NCoR, failed to exhibit the same in-
creases with Fads or Scd2 knockdown (Figures S3B and S3C).
Taken together, these data are consistent with the hypothesis
that NCoR depletion derepresses LXR, leading to increased
expression of select lipid metabolic target genes in the POA
and u3 FA biosynthetic pathways.
u3 FAs Suppress Transcriptional Outputs of NF-kB
Regulatory Elements
To specifically address the relationship of the hyporesponsive
phenotype of MNKO macrophages to NF-kB-dependent gene
expression, we assessed NF-kB-driven reporter gene activity
in MNKO and WT macrophages. Reporter activity of constructs,
driven by either NF-kB-bound enhancer regions from MNKO
hyporesponsive genes (Nos2 and Cxcl10) or a consensus NF-Figure 6. Increased u3 Fatty Acid in i.p. Macrophages from MNKO Mic
(A) ALA, EPA, DHA, and Pamitoleic acid content in vehicle or KLA-treated i.p. m
(B–D) (B) EPA level, DHA level (C), and pamitoleate level (D) in different lipid frac
(E) Effects of u3 fatty acid treatment on inflammatory gene expression in KLA-tr
(F–H) (F) KLA-induced inflammatory gene expression in i.p. macrophages after s
Values are expressed as mean ± SEM. *p < 0.05, **p < 0.01, y p < 0.001 for KO v
(Scd2, Elovl5, or Fads2) versus siCTL in (F)–(H). See also Figure S3.kB response element, exhibited significantly reduced activity in
MNKO versus WT macrophages (Figure S4A). Next, we per-
formed ChIP-seq measurements of the p65 component of NF-
kB to determine whether reduced NF-kB activity was due to a
reduction in DNA binding. Unexpectedly, ChIP-seq analysis
revealed a very similar pattern of p65 binding following KLA
stimulation in both WT and MNKO macrophages. Motif analysis
confirmed these as bona fide p65 binding sites, with highest
enrichment for NF-kB motifs, as well as motifs for macrophage
lineage-determining factorsPU.1, AP-1, andC/EBP (FigureS4B).
The similarity in p65 binding was observed not only for the entire
set of p65 binding sites associated with TLR4-responsive genes
induced > 2-fold in WT macrophages (Figure 7A) but also for the
subset of p65 binding sites associated with MNKO hyporespon-
sive loci (Figures 7B–7D), exemplified by the Cxcl10 locus (Fig-
ure 7E). These sites were also associated with increased
H4K5ac following TLR4 stimulation (Figure 7F), indicating that
binding of NF-kB resulted in recruitment of histone acetyltrans-
ferases. These findings indicate that much of the reduction in
expression of NF-kB target genes in MNKO macrophages is in-
dependent of changes in NF-kB binding and occurs at a step
subsequent to histone acetylation. Recent studies have impli-
cated histone H3 lysine 4 mono- and dimethylation (H3K4me1
and H3K4me2) as additional indicators of active local transcrip-
tion (Ng et al., 2003; Ostuni et al., 2013). In an effort to resolve the
paradox of increased histone acetylation and undiminished p65
binding at hyporesponsive genes in the MNKO cells, we per-
formed ChIP-seq analysis of H3K4me2 inWT andMNKOmacro-
phages. These studies revealed that MNKO macrophages
demonstrated significantly reduced levels of TLR4-dependent
H3K4me2 deposition at hyporesponsive genes, as shown for
the Cxcl10 locus (Figure 7E). This pattern of reduced H3K4me2
deposition, at both p65-bound enhancer elements and within
the associated gene bodies, was observed for the entire set of
hyporesponsive genes (Figures 7G and S4C). Conversely, genes
that are derepressed in MNKO macrophages exhibit increased
H3K4me2 levels, exemplified by theMmp12 locus (Figure S4D).
In addition to H3K4 methylation, recent studies have demon-
strated that enhancers direct the expression of eRNAs that are
linked to enhancer activity (Lai et al., 2013). Because GRO-seq
analysis not only identifies nascent mRNA transcripts but also
enables quantification of eRNAs, we also evaluated eRNA
expression at p65 binding sites associated with hyporesponsive
genes. This analysis indicated significantly reduced eRNA pro-
duction in MNKO-derived macrophages following TLR4 activa-
tion (Figure 7H). Interestingly, in contrast to these defects in
the NF-kB transcriptional pathway, we found no differences in
JNK activity betweenWT andMNKOmacrophages (Figure S4E),
which is consistent with both the transcriptomic results and the
view that the primary effects of u3 FAs in the MNKO cells aree
acrophages from WT and MNKO mice.
tions in i.p. macrophages from WT and MNKO mice.
eated WT and MNKO i.p. macrophages.
iRNA knockdown of Elovl5, Fads2 (G), or Scd2 (H).
ersus WT, or EPA-KLA versus KLA in (E), or KLA-treated target-specific siRNA
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Figure 7. Increased u3 FA Production Leads to Decreased NF-kB Activity in i.p. Macrophages of MNKO Mice
(A) Venn diagram of overlap between p65 peaks within 50 kb of TLR4-responsive genes (WT fold change > 2, RPKM> 0.1, and FDR < 0.05) in KLA-treatedWT and
MNKO macrophages.
(B) Venn diagram of overlap between p65 peaks within 50 kb of MNKO hyporesponsive genes in KLA-treated WT and MNKO macrophages.
(C) Normalized distribution of for p65 ChIP-seq tag counts at enhancer-like regions associated withMNKO hyporesponsive genes (defined in B) in vehicle or KLA-
treated WT and MNKO macrophages.
(D) Scatterplot of normalized tag counts for p65 at enhancer-like regions associated with TLR4-responsive genes (defined in A) in KLA-treated MNKO and WT
macrophages. The p65 peaks corresponding to hyporesponsive genes in MNKO macrophages (defined in B) are highlighted in red. The Pearson’s correlation
coefficient is reported in the figure (p < 0.0001).
(legend continued on next page)
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intracellular. Together, these findings provide evidence that loss
of NCoR leads to uncoupling of p65 binding and local TLR-
dependent histone acetylation from histone methylation and
eRNA production, resulting in reduced signal-responsive gene
expression.
To directly link these observations to effects of u3 FAs on
NF-kB activity, we evaluated effects of EPA and DHA on
NF-kB-driven reporter genes in primary WT macrophages.
These experiments demonstrated the expected decrease in re-
porter gene activity (Figure S4F). Importantly, ChIP assays indi-
cated that u3 treatment of WT macrophages resulted in
decreased TLR-dependent deposition of H3K4me2 (Figure 7I)
with no changes in p65 binding (Figure 7J) at p65 binding sites
in enhancers associated with the Nos2 andCxcl10 genes. These
observations suggest that u3 fatty acids suppress the transcrip-
tional functions of p65 at a step downstream of NF-kB binding.
DISCUSSION
Here, we present evidence that deletion of NCoR from macro-
phages results in an anti-inflammatory phenotype with protec-
tion from systemic insulin resistance in the setting of HFD-
induced obesity. This surprising phenotype in the MNKO mice
was manifested by decreased macrophage accumulation in
adipose tissue, decreased expression of inflammatory pathway
genes, and reduced cytokine protein levels. In addition, we
observed improved glucose tolerance in these animals, as well
as systemic insulin sensitivity, asmeasured by the hyperinsuline-
mic euglycemic clamp method. Interestingly, treatment with ro-
siglitazone had little further effect to augment insulin sensitivity in
theMNKOmice, possibly because theywere already insulin sen-
sitive in the untreated state or because the anti-inflammatory
effects attributable to rosiglitazone (Bouhlel et al., 2007; Ode-
gaard et al., 2007) require NCoR (Pascual et al., 2005). This
improvement in inflammatory status and insulin sensitivity rein-
forces the connection between macrophage-mediated tissue
inflammation and insulin resistance. In vitro studies further
demonstrated that, although some inflammatory response
genes were upregulated in MNKO cells, a substantially larger
number exhibited hyporesponsiveness to TLR4 ligation.
NCoR and the related protein SMRT were initially discovered
based on their functions as corepressors of retinoic acid and
thyroid hormone receptors (Chen and Evans, 1995; Ho¨rlein
et al., 1995). Subsequent studies extended these corepressor
functions to additional nuclear receptors, including LXRs (Hu
et al., 2003), as well as a number of signal-dependent transcrip-
tion factors such as AP-1, NF-kB, and Ets (Mottis et al., 2013).(E) UCSC genome browser image illustrating normalized tag counts for H3K4me
2012) in WT and MNKO macrophages for the Cxcl10 genomic locus as indicated
(F) Normalized distribution of H4K5Ac ChIP-seq tag density in the vicinity of p6
(defined in B) in vehicle or KLA-treated WT and MNKO macrophages.
(G) Normalized distribution of H3K4me2 ChIP-seq tag density in the vicinity of p
(defined in B) in KLA-treated cells.
(H) Normalized distribution of GRO-seq tag counts in the vicinity of p65 peaks a
treated cells.
(I) ChIP for H3K4me2 at Nos2 and Cxcl10 loci in WT macrophages treated with K
(J) ChIP for p65 at Nos2 and Cxcl10 loci in WT macrophages treated with KLA in
Values are expressed as mean ± SEM. *p < 0.05 and **p < 0.01 for KLA versus EThe corepressor activities of NCoR and SMRT are based on their
ability to serve as platforms for the assembly of large core-
pressor complexes, with a core NCoR/SMRT complex contain-
ing Tbl1, TblR1, HDAC3, and GPS2 (Rosenfeld et al., 2006).
HDAC3 contributes directly to the corepressor activity of
NCoR/SMRT complexes by catalyzing the removal of histone
acetylation marks that are involved in transcriptional activation
(Codina et al., 2005).
Genome-wide analysis confirmed increased H4K5 acetylation
inMNKO cells at genome sites where NCoR is bound inWT cells,
which is consistent with loss of recruitment of HDAC3 due to the
NCoR deletion. At these sites, acetylation of histone H4 at lysine
residues is linked to recruitment of pTEFb, which is associated
with increased transcriptional elongation (Yang et al., 2005).
However, increased H4K5ac was observed not only at genes
exhibiting increased expression in MNKO cells but also at the
large subset of TLR4-responsive genes exhibiting impaired
KLA stimulation (hyporesponsive gene set, Figure 4E). In addi-
tion, our p65 ChIP-seq results showed unimpaired p65 occu-
pancy of the promoters/enhancers for these hyporesponsive
genes. Thus, even when NF-kB binds to its target genes at hy-
peracetylated sites, its transcriptional functions are compro-
mised in NCoR-deficient macrophages. These observations
indicate a paradoxical uncoupling of histone acetylation and
p65 DNA binding from transcriptional activation.
Investigation of possible causes of the hyporesponsive
phenotype of MNKO macrophages led to the finding of dere-
pression of LXR target genes involved in generation of anti-
inflammatory fatty acids, including long-chain u3-FAs and
POA. Thus, NCoR can bind to LXR,mediating basal transcription
repression at NCoR/LXR binding sites. In the absence of NCoR,
LXR is derepressed, leading to increased transcription of these
targets, which include the lipogenic genes Elovl5, Fads1,
Fads2, Scd1, and Scd2. These lipogenic genes drive the biosyn-
thesis of u3 FAs and POA within macrophages, effectively re-
programming macrophage lipid metabolism. Derepression of
these genes was not observed in fetal liver-derived macro-
phages from systemic NCoR KO mice (Ghisletti et al., 2009),
which may account for the relatively activated phenotype re-
ported for those cells. Administration of these u3 FAs was less
effective at inhibiting TLR4 responses in MNKO cells, consistent
with the elevated endogenous levels. Conversely, knockdown of
the lipogenic enzymes responsible for their production partially
restored inflammatory responses in NCoR KO cells. These re-
sults support the conclusion that increased expression of anti-
inflammatory FAs contribute to the hyporesponsive phenotype
of MNKO cells. The relative importance of anti-inflammatory2 ChIP-seq, GRO-seq, p65 ChIP-seq, and NCoR ChIP-seq (from Barish et al.,
.
5 binding sites at enhancers associated with MNKO hyporesponsive genes
65 binding sites at enhancers associated with MNKO hyporesponsive genes
ssociated with MNKO hyporesponsive genes (defined in B) in vehicle or KLA-
LA in the presence or absence of EPA.
the presence or absence of EPA.
PA-KLA. See also Figure S4.
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FAs appears to vary in a gene-specific manner, indicating that
additional mechanisms contribute.
Genome-wide and locus-specific analyses indicate that u3
FAs provide at least two levels of suppression of inflammatory
response genes. u3 FAs exert anti-inflammatory effects by
serving as agonists for GPR120 on macrophages (Oh et al.,
2010). GPR120 ligation inhibits proinflammatory signaling by
blocking activation of TAK1 with reduced downstream signaling
to IKKb/NF-kB (Oh et al., 2010). This, in turn, would result in
reduced translocation of NF-kB to the nucleus. Consistent with
this prediction, reduced occupancy of p65 was observed on a
subset of inflammatory gene promoters and enhancers in the
NCoR-deficient macrophages and in WT macrophages treated
with u3 FAs. However, this effect was quantitative and locus
specific, with the great majority of TLR4 hyporesponsive genes
remaining largely or fully occupied by p65. Consistent with
this, we found no decrease in JNK activity in the MNKO macro-
phages compared to WT. This indicates that, in MNKO cells, the
major effects of endogenously produced u3 FAs are intracellular
and largely independent of GPR120. Furthermore, these sites of
p65 binding exhibited increased H4K5ac, which requires the
active recruitment of histone acetyltransferases such as
CREB-binding protein (CBP) and p300 by active NF-kB. In
contrast, H3K4 dimethylation and enhancer RNA production
were consistently inhibited at genomic regulatory elements
associated with the hyporesponsive genes. Previous studies
have demonstrated local deposition of H3K4me2 as a valid mea-
sure of signal-responsive transcription factor activity (He et al.,
2010). Further, signal-dependent inductions of H3K4me2 and
transcriptional output from local transcription-factor-activated
enhancers reflect the increased induction of associated genes
(He et al., 2010; Ostuni et al., 2013). Reduced H3K4me2 levels
were further correlated with reduced eRNA production at p65
enhancers associated with hyporesponsive genes, which is
further indicative of a loss of transcriptional output of NF-kB at
these locations. Thus, although histone acetylation and p65
DNA binding are required for activation, they are not sufficient
to promote transcriptional activation of the hyporesponsive in-
flammatory gene set in the context of NCoR deletion or u3 FA
treatment.
Together, the present studies provide evidence in support of
two main conclusions. First, these observations suggest that
macrophages can be a source of sufficient u3 FAs and POA to
exert autocrine and/or paracrine effects that result in improved
insulin sensitivity. This concept is also exemplified by our find-
ings that the normal effects of CM harvested from WT macro-
phages to inhibit insulin-stimulated glucose transport do not
occur using CM from MNKO macrophages. That these u3 FAs
effects are local is supported by our data demonstrating
increased levels of u3 FAs in macrophages without changes in
systemic concentrations. This concept raises the possibility
that treatments, which could reprogrammacrophage lipid meta-
bolism into the more metabolically favorable state characteristic
of NCoR macrophage KO mice, could have important therapeu-
tic effects to reduce tissue inflammation and promote insulin
sensitivity. Second, these findings reveal a molecular function
of unsaturated u3 FAs by which they reduce H3K4 methylation,
enhancer transcription, and mRNA expression at regulatory ele-212 Cell 155, 200–214, September 26, 2013 ª2013 Elsevier Inc.ments that control inflammatory response genes and thereby
establish a hyporesponsive state. These effects are due to
reduced NF-kB complex activity independent of effects on NF-
kB localization itself. Identification of the molecular targets and
mechanisms responsible for these effects could also lead to
development of new approaches for diseases characterized by
pathogenic forms of inflammation.
EXPERIMENTAL PROCEDURES
Animal Care and Use
Animals were maintained on a 12 hr/12 hr light/dark cycle with free access to
food and water. All animal procedures were in accordance with University of
California, San Diego research guidelines for the care and use of laboratory
animals.
Creation of Control and Monocyte/Neutrophil-Specific NCoR KO
Mice
NCoRfl/fl mice were generated as described previously (Li et al., 2011). To
generate macrophage/neutrophil-specific NCoR null mice, NCoRfl/fl were
bred with transgenic mice harboring Cre recombinase driven by myeloid-spe-
cific lysozyme M promoter (Clausen et al., 1999) to create the following geno-
types: NCoRfl/fl (control) and NCoRfl/fl-LysMCre (MNKO). These mice were
backcrossed to the C57BL/6J strain for more than ten generations.
Lipid Measurements
Thioglycollate-elicited peritoneal macrophages were plated at 2.0 3 106 cells
per well of a 6-well plate in growth medium containing RPMI 1640 (with
L-glutamine) (Invitrogen) plus 10% heat-inactivated FBS (Hyclone). After
24 hr, cells were washed twice with PBS and switched to culture medium con-
taining RPMI 1640 (Invitrogen) without serum and supplemented with FA-free
BSA (sigma) for 6 hr. Media and cells were collected for detection and quanti-
tation of lipids by mass spectrometric methods as described previously
(Brown et al., 2007).
Lipid Fraction Analyses in Macrophages
The lipids from thioglycollate-elicited macrophages were extracted in the
presence of authentic internal standards by the method of Folch et al.
(1957). Using chloroform:methanol (2:1 v/v), individual lipid classes within
each extract were separated by liquid chromatography (Agilent Technologies
model 1100 series). Each lipid class was transesterified in 1% sulfuric acid in
methanol in a sealed vial under a nitrogen atmosphere at 100C for 45min. The
resulting fatty acid methyl esters were extracted from the mixture with hexane
containing 0.05% butylated hydroxytoluene and prepared for gas chromatog-
raphy by sealing the hexane extracts under nitrogen. Fatty acid methyl esters
were separated and quantified by capillary gas chromatography (Agilent Tech-
nologies model 6890) equipped with a 30 m DB-88MS capillary column
(Agilent Technologies) and a flame-ionization detector.
High-Throughput Sequencing and Data Analysis
ChIP fragments were sequenced for 36 or 50 cycles on an Illumina Genome
Analyzer or HiSeq 2000, respectively, according to the manufacturer’s instruc-
tions. GRO-seq results were trimmed to remove A-stretches originating from
the library preparation. Each sequence tag returned by the Illumina Pipeline
was aligned to the mm9 assembly using ELAND, allowing up to two mis-
matches. Only tags that mapped uniquely to the genome were considered
for further analysis.
Data analysis was performed using HOMER, and the detailed instructions
for analysis can be found at http://biowhat.ucsd.edu/homer/ or as previously
described in Heinz et al. (2010). Each sequencing experiment was normalized
to a total of 107 uniquely mapped tags by adjusting the number of tags at each
position in the genome to the correct fractional amount given the total tags
mapped. Sequencing experiments were visualized by preparing custom
tracks for the UCSC genome browser. GRO-seq density within gene bodies
was determined by adding the number of tags within the gene body defined
by RefSeq and normalizing by the length of the gene. Differentially expressed
genes were identified as described previously (Escoubet-Lozach et al., 2011),
using log values of gene body tag densities to calculate indicated fold change
thresholds. For gene ontology analysis, DAVID Bioinformatics Resources 6.7
was used.
For additional methods, see the Extended Experimental Procedures.
Statistical Analyses
Statistical analyses were performed using Excel or GraphPad Prism 5. The
images were prepared using Photoshop CS5.1 or GraphPad Prism 5. Data
are presented as the mean ± SEM. For experiments involving two factors,
data were analyzed by two-way ANOVA followed by Bonferroni post tests. In-
dividual pair-wise comparisonswere performed using Student’s t test. p < 0.05
was considered significant.
ACCESSION NUMBERS
Sequencing data supporting these studies can be found at the Gene Expres-
sion Omnibus database under accession number GSE50944. Data from
previously published ChIP-seq experiments can be found under accession
numbers GSE27060 and GSE33596.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and one table and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.08.054.
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